CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events

scientific article

CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.YJMCC.2008.06.003
P698PubMed publication ID18619972
P5875ResearchGate publication ID5232528

P50authorJ Wouter JukemaQ64858750
Saskia C A de JagerQ73812155
Douwe Ekke AtsmaQ89053244
Martin Jan SchalijQ89053249
Erik A L BiessenQ114371052
Bas L van der HoevenQ114403325
P2093author name stringHein Putter
Theo J C van Berkel
Berent J Prakken
Wilco de Jager
Su-San Liem
Adriaan O Kraaijeveld
Robert W Grauss
P2860cites workPravastatin suppresses the interleukin-8 production induced by thrombin in human aortic endothelial cells cultured with high glucose by inhibiting the p44/42 mitogen activated protein kinaseQ28362055
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.Q33183129
Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3.Q33212030
Stem cell-related cardiac gene expression early after murine myocardial infarctionQ33268468
Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cellsQ34579137
Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.Q35047585
The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in ratsQ35844081
Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarctsQ36509613
CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptomsQ40168375
Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditionsQ40420958
Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endotheliumQ40423150
Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular riskQ40753513
Non-lipid effects of statin on hypercholesterolemic patients established to have coronary artery disease who remained hypercholesterolemic while eating a step-II dietQ43654962
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.Q44063984
RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patientsQ44506407
Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromesQ44579499
Serum MCP-1 and VEGF levels are not affected by inhibition of the renin-angiotensin system in patients with acute myocardial infarctionQ44628723
Inhibitory effect of pitavastatin (NK-104) on the C-reactive-protein-induced interleukin-8 production in human aortic endothelial cellsQ45257699
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapyQ46191844
Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia.Q46434904
Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protectionQ47433273
Molecular dynamics of the compensatory response to myocardial infarct.Q52061500
Elevated plasma interleukin-6 levels in patients with acute myocardial infarctionQ72630338
Relationship between CRP and clinical course of unstable angina depends on assay methodQ73078663
Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarctionQ73088379
Platelet-derived CD40L: the switch-hitting player of cardiovascular diseaseQ74627856
Changes in serum interleukin-8 and interleukin-12 levels in patients with ischemic heart disease in a Chinese populationQ77094964
Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell functionQ77777637
Serum profiles of C-C chemokines in acute myocardial infarction: possible implication in postinfarction left ventricular remodelingQ77815083
Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery diseaseQ79374759
MISSION!: optimization of acute and chronic care for patients with acute myocardial infarctionQ79438237
Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002Q79851935
Simvastatin exerts its anti-inflammatory effect in hypercholesterolaemic patients by decreasing the serum levels of monocyte chemoattractant protein-1Q80073011
Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndromeQ80288412
Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosisQ80431554
The role of the chemokines in myocardial ischemia and reperfusionQ80472753
Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodiesQ81751909
Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarctionQ82458639
Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarctionQ82917837
P433issue3
P921main subjectacute coronary syndromeQ266018
P1104number of pages7
P304page(s)446-452
P577publication date2008-06-21
P1433published inJournal of Molecular and Cellular CardiologyQ2061932
P1476titleCCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events
P478volume45

Reverse relations

cites work (P2860)
Q92153753A Pro-Inflammatory Biomarker-Profile Predicts Amputation-Free Survival in Patients with Severe Limb Ischemia
Q38826694CC chemokine ligands in patients presenting with stable chest pain: association with atherosclerosis and future cardiovascular events
Q39035199Cardiometabolic biomarkers are predictors of readmission and death in patients hospitalized for acute dyspnea
Q34672038Chemokine receptor CCR5: from AIDS to atherosclerosis
Q34430115Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes
Q37486616Chemokines as therapeutic targets for atherosclerotic plaque destabilization and rupture
Q37547865Conditional deletion of cardiomyocyte peroxisome proliferator-activated receptor γ enhances myocardial ischemia-reperfusion injury in mice
Q39895236From multimarker approach to multiplex assays in acute coronary syndromes: what are we searching for?
Q35633277Is PCOS an inflammatory process?
Q39867198Macrophage inflammatory protein-1beta induced cell adhesion with increased intracellular reactive oxygen species
Q30440919Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging
Q34312170PEG-albumin plasma expansion increases expression of MCP-1 evidencing increased circulatory wall shear stress: an experimental study
Q33576883PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease
Q38810989Prognostic value of plasma biomarkers in patients with acute coronary syndrome: a review of advances in the past decade.
Q37660659The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue

Search more.